We are using infectious disease genomics to investigate how pathogenic viruses such as Zika, West Nile, Ebola, and Lassa emerge and cause large-scale outbreaks. Using a combination of computational biology, experimentation, and field work, our hope is to transform outbreak response and change the way we develop vaccines and therapeutics.
Launch of CViSB U19 Center
With a $15 million U19 center grant from the NIH National Institute of Allergy and Infectious Diseases, we are excited to announce that we have established the Center for Viral Systems Biology (CViSB; https://cvisb.org). This highly collaborative work spans scientific boundaries and our mission is to use high-throughput experimental and computational approaches to elucidate how some people are able to survive Ebola and Lassa virus infections. Kristian will serve as the principal investigator of the center, and together with Bob Garry from Tulane University, will be the co-director of CViSB. The center is a large-scale international collaboration between Scripps Research, Kenema Government Hospital, Tulane University, UCLA, Harvard, and MIT.
The establishment of the CViSB center will allow our lab to expand into new exciting scientific avenues. Utilizing the technological, biological, and computational resources we have generated over the last couple of years, we will be able to turn our focus to understanding disease in individual patients, in addition to our prior work elucidating the forces driving outbreaks. We are very excited about this new work, and we invite talented candidates to apply for some of the many jobs the creation of this center has allowed. Please have a look at the jobs section of our website, or check out the jobs section on the CViSB website.